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Background. Bipolar disorder (BD) is one of the leading causes of disability worldwide. Patients are further
disadvantaged by delays in accurate diagnosis ranging between 5 and 10 years. We applied Gaussian process classiﬁers
(GPCs) to structural magnetic resonance imaging (sMRI) data to evaluate the feasibility of using pattern recognition
techniques for the diagnostic classiﬁcation of patients with BD.
Method. GPCs were applied to gray (GM) and white matter (WM) sMRI data derived from two independent samples of
patients with BD (cohort 1: n=26; cohort 2: n=14). Within each cohort patients were matched on age, sex and IQ to an
equal number of healthy controls.
Results. The diagnostic accuracy of the GPC for GM was 73% in cohort 1 and 72% in cohort 2; the sensitivity and
speciﬁcity of the GM classiﬁcation were respectively 69% and 77% in cohort 1 and 64% and 99% in cohort 2. The
diagnostic accuracy of the GPC for WM was 69% in cohort 1 and 78% in cohort 2; the sensitivity and speciﬁcity of
the WM classiﬁcation were both 69% in cohort 1 and 71% and 86% respectively in cohort 2. In both samples, GM
and WM clusters discriminating between patients and controls were localized within cortical and subcortical structures
implicated in BD.
Conclusions. Our results demonstrate the predictive value of neuroanatomical data in discriminating patients with BD
from healthy individuals. The overlap between discriminative networks and regions implicated in the pathophysiology
of BD supports the biological plausibility of the classiﬁers.
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Introduction
Bipolar disorder (BD) is a complex psychiatric disorder
characterized by severe mood dysregulation (APA,
1994). BD is associated with signiﬁcant psychosocial
morbidity and mortality (Angst et al. 2002; Baldessarini
& Tondo, 2003) and is among the leading causes of
disability worldwide (WHO, 2004). Despite illness sev-
erity, the delay between onset and accurate diagnosis
is typically between 5 and 10 years (Lish et al. 1994;
Hirschfeld et al. 2003; Berk et al. 2007). Surveys of BD
patients conducted over the past 20 years show no evi-
dence of improvement in timely illness recognition
(Hirschfeld et al. 2003; WHO, 2004; Berk et al. 2007).
Delayed diagnosis in BD has adverse consequences
in terms of increased periods in episode, greater psy-
chosocial morbidity (Stensland et al. 2008) and emer-
ging treatment resistance (Post et al. 2003; Ketter et al.
2006). Delayed diagnosis is also associated with
increased treatment costs (Stensland et al. 2008)
whereas early and accurate identiﬁcation of BD leads
to signiﬁcant cost savings (Menzin et al. 2009). The
importance of early recognition in BD is further
underscored by emerging yet compelling evidence
that the illness is associated with evolving neurobio-
logical changes that may drive subsequent clinical
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deterioration (Berk et al. 2009; Kapczinski et al. 2009).
Therefore, the timely diagnosis of BD is currently
the single most important unmet need in enhancing
clinical and functional outcomes.
Neuroimaging studies to date have established that
structural magnetic resonance imaging (sMRI) can be
used to identify brain morphological differences be-
tween BD patients and controls. Meta-analytic studies
that have synthesized the extensive available literature
have conﬁrmed that BD is reliably associated with
structural abnormalities in the ventral prefrontal cortex,
the cingulate gyrus, amygdala/parahippocampal com-
plex and the basal ganglia (Kempton et al. 2008;
Arnone et al. 2009; Vita et al. 2009; Bora et al. 2010;
Ellison-Wright & Bullmore, 2010; Kempton et al.
2011; Selvaraj et al. 2012). Despite the contribution of
these ﬁndings to our understanding of the patho-
physiology of BD, their clinical usefulness has been
negligible. This is primarily because conventional
sMRI data analyses compute mean group differences
in spatial localized anatomical regions and do not
make use of information about the distributed pattern
of relationships among regions or voxels. Information
about these spatial patterns is of particular relevance
as it can be used for the diagnostic classiﬁcation of
individual patients, thus bridging the gap between
neuroscience and clinical practice. In this respect,
recent advances in multivariate pattern recognition
techniques represent a major development.
The most commonly used pattern recognition algor-
ithm has been the support vector machine (SVM)
classiﬁer. The SVM classiﬁer has been used for the
classiﬁcation of patients with Alzheimer’s disease
(Klöppel et al. 2008; Vemuri et al. 2008), autism
(Ecker et al. 2010), aphasia (Wilson et al. 2009) and psy-
chosis (Koutsouleris et al. 2009; Mourao-Miranda
et al. 2012) and to predict clinical variables based on
patterns of brain activation in functional MRI
(Fu et al. 2008; Marquand et al. 2008). However, the
SVM classiﬁer yields binary (case or control) and not
probabilistic outcomes. For many applications, prob-
abilistic predictions are desirable as they have two
key advantages: they provide accurate quantiﬁcation
of predictive uncertainty, reﬂecting variability within
subject groups (e.g. in quantifying the probability
that a subject has a psychiatric disorder within a popu-
lation where illness severity can be expected to vary
between individuals), and they allow adjustment of
predictions to compensate for different frequencies
of diagnostic classes within the general population
(Bishop, 2006). Gaussian process classiﬁers (GPCs) rep-
resent a signiﬁcant advance over SVM as they are fully
probabilistic pattern recognition models based on
Bayesian probability theory. For neuroimaging, GPCs
combine equivalent predictive performance to SVM
with the additional beneﬁt of probabilistic classiﬁ-
cation (Marquand et al. 2010).
Therefore, we used GPCs to examine the predictive
value of whole-brain gray (GM) and white matter
(WM) anatomy in discriminating patients with BD
from healthy individuals. We embedded the classiﬁer
in a recursive feature elimination (RFE) framework
(Guyon et al. 2002; Marquand et al. 2011) to identify
and localize the subset of brain voxels that provide
optimal discrimination accuracy. We focused on
sMRI, rather than other neuroimaging techniques, as
it is widely available, safe and has an established role
in the diagnosis and management of brain disorders.
Thus, a diagnostic aid based on sMRI data could be
easily incorporated into routine clinical practice and
is likely to have high patient acceptability. We enrolled
patients with bipolar disorder, type 1 (BP-I; APA,
1994), whose diagnosis was further conﬁrmed follow-
ing detailed clinical assessment. Patients were in remis-
sion, free of any other lifetime psychiatric co-morbidity
and matched to healthy controls on age, sex and gen-
eral intellectual ability (IQ). This careful sample selec-
tion was designed to maximize the probability that
discrimination between patients and controls would
be attributable to brain structural changes relating to
BD rather than other factors such as co-morbidity or
general cognitive ability. Furthermore, we included
two independent cohorts of patients and controls to
determine the reliability of our ﬁndings.
Method
Samples
Cohort 1 comprised 26 patients fulﬁlling criteria for
BP-I according to DSM-IV criteria (APA, 1994) and
26 healthy controls derived from participants in the
Maudsley Bipolar Disorder Project (Frangou, 2005;
Frangou et al. 2005). Demographic and clinical infor-
mation on the sample is shown in Table 1. Nineteen
BD patients were prescribed psychotropic medications,
often in combination (typical antipsychotics=4, atypi-
cal antipsychotics=4, lithium=10, carbamazepine=7,
sodium valproate=2). None of the patients were pre-
scribed benzodiazepines, anticholinergics or any other
medication.
Cohort 2 comprised 14 patients fulﬁlling DSM-IV
criteria for BP-I and 14 healthy controls derived from
participants in the Vulnerability Indicators to Bipolar
Disorder Study (VIBES; Frangou, 2009). Demographic
and clinical information on the sample is shown in
Table 1. All patients in this sample were on treatment
with anticonvulsant (sodium valproate=10, carbama-
zepine=4) monotherapy and did not receive any
other type of medication.
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For both samples, patients had an established
diagnosis of BD and were receiving out-patient treat-
ment within secondary care services. They were indivi-
dually matched on sex, age and IQ to an equal number
of healthy controls without a personal or family his-
tory of any DSM-IV Axis I disorders. All participants
were screened to exclude past, current and hereditary
neurological disorders, current medical conditions,
DSM-IV current or lifetime drug or alcohol depen-
dence or abuse, and other DSM-IV Axis I current or
lifetime co-morbidity and contraindications to MR
imaging. All participants were assessed by qualiﬁed
psychiatrists using the Structured Clinical Interview
for DSM-IV for Axis I Disorders, Patient or Non-
Patient Version (SCID-I/P and SCID-I/NP; First et al.
2002a,b) and the Family Interview for Genetic Studies
(FIGS; Maxwell, 1992), with additional information
supplemented by medical notes as appropriate. Psy-
chopathology was assessed using the Hamilton De-
pression Rating Scale (HAMD; Hamilton, 1960) and
the Mania Rating Scale (MRS; Spitzer & Endicott,
1978), and psychosocial functioning was assessed
with the Global Assessment of Functioning (GAF)
scale (APA, 1994). Patients were scanned when in
remission operationalized as (a) the absence of syndro-
mal episode for 53 months, (b) being prescribed
the same type and dose of medication for 53 months,
and (c) having HAMD and MRS total scores of <10 on
the day of scanning. An estimate of general intellectual
ability was obtained using the National Adult Reading
Test (NART; Nelson &Wilson, 1992). Patients in cohort
2 were younger, had an earlier age of onset and higher
IQ than those in cohort 1 (p<0.01).
This study was approved by the Joint Ethics
Committee of the Institute of Psychiatry and the
South London and Maudsley National Health Service
(NHS) Foundation Trust. Written informed consent
was obtained from all participants after a detailed
description of the study.
MRI data acquisition
Participants were scanned using a 1.5-T GE NV/i
Signa MR system (GE Medical Systems, USA) at the
Maudsley Hospital, London. The whole brain was
imaged with a three-dimensional (3D) inversion re-
covery prepared fast spoiled gradient-recalled acqui-
sition in the steady state (SPGR) T1-weighted dataset.
These T1-weighted images were obtained in the
axial plane with 1.5-mm contiguous sections (echo
time=5.1ms, repetition time=18ms, ﬂip angle=20°,
slice thickness=1.5 mm, in-plane resolution=0.9375×
0.9375mm, number of excitations=1). Image contrast
for all datasets was chosen with the aid of optimizing
software (Simmons et al. 1996).
Data preprocessing
For both samples, all images were ﬁrst visually
inspected for artifacts or gross structural abnormalities
using criteria described previously (Simmons et al.
1996, 2011). Subsequently, images were preprocessed
using SPM5 (www.ﬁl.ion.ucl.ac.uk/spm/software/
spm5). Using the uniﬁed segmentation step included
in SPM5, images were normalized and segmented
(Ashburner & Friston, 2005). Normalized and modu-
lated GM and WM segmented images were then
smoothed with 8-mm isotropic Gaussian kernels and
used as input into the classiﬁcation algorithms.
Pattern classiﬁcation analysis
The probability of group membership was determined
separately in each cohort using GPCs to the MRI data.
Table 1. Demographic and clinical characteristics of the study samples
Cohort 1 Cohort 2
Patients with
BD (n=26)
Healthy controls
(n=26)
Patients with
BD (n=14)
Healthy controls
(n=14)
Age (years) 41.5 (11.27) 41.3 (11.65) 37.6 (11.97) 37.4 (10.98)
Male:Female 12:14 12:14 6:8 6:8
IQ 102.3 (15.93) 103.3 (17.37) 108.6 (16.88) 110.9 (18.99)
Age of onset (years) 25.7 (9.22) – 18.8 (7.43) –
HAMD 6.6 (3.39) – 4.2 (5.15) –
MRS 1.8 (4.11) – 1.7 (3.12) –
GAF 71.1 (11.31) – 70.2 (24.14) –
BD, Bipolar disorder; HAMD, Hamilton Depression Rating Scale; MRS, Mania Rating Scale; GAF, Global Assessment of
Functioning.
Continuous data expressed as mean (standard deviation).
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Technical descriptions of GPC inference have been
presented elsewhere (Bishop, 2006; Rasmussen &
Williams, 2006; Marquand et al. 2008, 2010) and are
summarized in the online Supplementary Material.
In brief, the classiﬁer is ﬁrst trained to determine a pre-
dictive distribution that best distinguishes cases from
controls; any parameters controlling the behavior of
this distribution are computed by maximizing the
logarithm of the marginal likelihood on the training
data only. Then, in the test phase, the classiﬁer predicts
the groupmembership of a previously unseen example.
This is achieved by integrating over the predictive
distribution for the test case and passing the output
through a sigmoidal function, resulting in predictive
probabilities scaled between 0 and 1 that precisely quan-
tify the predictive uncertainty of the classiﬁer for the test
case.
In each cohort, the GPCs for GM and WM were
implemented separately in the PROBID software
package (http://www.kcl.ac.uk/iop/depts/neuroimaging/
research/imaginganalysis/Software/PROBID.aspx). We
embedded each classiﬁer in a recursive feature elimin-
ation (RFE) framework (Guyon et al. 2002; Marquand
et al. 2011), which enabled us to identify the subset of
(a) Training Phase
Examples of Class 2Examples of Class 1
GPC weight vector
Discrimination map Predictive value
Class 1
+5 +5
(b) Test Phase
Subject 1
Feature vector
~σ[(+5*0.5)+(–5*0.2)) = σ(0.5)
Predictive value
Class 2
Subject 2
Feature vector
~σ[(+5*0.5)+(–5*0.8)) = σ(–1.5)
Fig. 1. A hypothetical example based on a simpliﬁed version of the Gaussian process classiﬁer (GPC) decision function
considering two gray matter (GM) voxels per image. To provide an intuitive interpretation of the maps, we consider a
simpliﬁed version of the GPC decision function. The class probability p is given by ply=class 11 x, w)=o(xt wI, where y is
the class label of a test subject (if y>05 corresponds to class 1, otherwise it corresponds to class 2), x is the feature vector
containing gray matter voxels for the test subject, wis referred to as the maximum a posteriori estimate of the GPC weight
vector, and is the best point estimate of the GPC decision function (i.e. the mode of the Gaussian approximation in voxel
space) and a is a sigmoid function that maps the values to the interval [0,1). (A) Training phase: Through training the GPC
classiﬁer assigns for each voxel a weight value w=(+5, −5); +5 represents a voxel containing predictive contribution for class 1
displayed in red and −5 represents a voxel containing predictive contribution for class 2 (displayed in blue). (S)Test Phase:
The feature vector (vector containing gray matter probability assigned for each voxel) is shown within each of the two voxels
in the two-voxel image example. During the test phase, for classifying a new example we ﬁrst mUltiplied each voxel by its
corresponding coefﬁcient in the weight vector. After that we add all multiplied values and pass the sum through a sigmoid
function in order to obtain an output (i.e. predictive probabilities) between 0 and 1. In the illustrative eKample above: Subject
1: The feature vector for this subject is (0.5, 0.2). The predictive value for this subject is 0[(+5*0.5)+ (−5*0.2))=0(0.5) which
corresponds to a predictive probability above 0.5. Therefore subject 1 will be classiﬁed as class 1. For the subject 1, a low
value in the voxel 2, which has negative coefﬁcient in the weightvector, contributed to the classiﬁcation of this subject as class
1. Subject 2: The feature vector for this subject is (0.5, 0.8). The predictive value for this subject is 0[(+5*0.5)+ (−5*0.8))=0(−1.5)
which corresponds to a predictive probability below 0.5. Therefore subject 2 will be classiﬁed as class 2. For subject 2, a high
value in the voxel2, which has a positive coefﬁcient in the weight vector, contributesto the classiﬁcation ofthis subject as
class 2.
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brain voxels that provided the optimal discrimination
accuracy and to accurately localize the most discrimi-
native brain voxels. To achieve this, we used nested
(three-way) cross-validation where we ﬁrst excluded
a matched pair of subjects (one from each group) to
comprise the test set, and then performed a second
split where we repeatedly repartitioned the remaining
subject pairs into a validation and a training set. We
then repeatedly trained the classiﬁer on the training
set, removing a subset of the least informative features
at each iteration, until no features remained. We used a
common ranking criterion based on the GPC predic-
tive weights to quantify the information content of
each voxel at each iteration (Marquand et al. 2011)
and used a small step size (∼1% of voxels) to provide
ﬁne-grained control over the number of features re-
tained. In each case we selected the number of features
that produced maximal accuracy on the validation set
before applying it to the test set. We thresholded the
probabilistic predictions at 0.5 to convert the probabil-
istic predictions to class labels and computed the pro-
portion of subjects having the correct label across all
test splits to estimate the classiﬁcation accuracy. The
statistical signiﬁcance of each classiﬁer was determined
by permutation testing. This test was used to derive a
p value to determine whether the classiﬁcation accu-
racy exceeded chance levels (50%). To achieve this,
we permuted the class labels from the training set
1000 times (i.e. each time randomly assigning class
labels to each structural MRI pattern) and repeated
the entire RFE procedure. We then counted the number
of times the permuted test accuracy was equal to or
greater than the one obtained for the true labels.
Dividing this number by 1000, we derived a p value
of the classiﬁcation accuracy.
Cross-validation
The performance of the GM and WM classiﬁers for
each cohort separately was estimated in four ways.
First, for each classiﬁer within each sample we com-
puted the proportion of images correctly classiﬁed as
BD patients or controls (i.e. classiﬁcation accuracy).
Second, we quantiﬁed the sensitivity and speciﬁcity
of each classiﬁer deﬁned as: sensitivity=TP/(TP+FN)
and speciﬁcity=TN/(TN+FP), where TP is the number
of true positives (number of images of patients cor-
rectly classiﬁed), TN is the number of true negatives
(number of images of controls correctly classiﬁed), FP
is the number of false positives (number of images of
controls classiﬁed as patients) and FN is the number
of false negatives (number of images of patients
classiﬁed as controls). Third, we compared the results
obtained through the GPCs to those derived from con-
ventional univariate voxel-based morphometry (VBM)
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implemented in SPM5. In VBM analyses we used a
statistical threshold of p<0.0001 uncorrected for
multiple comparisons. Thus we preserve a reasonable
degree of speciﬁcity in favor of increased sensitivity
as the aim of this analysis was to assist in making infer-
ences about the contribution of different regions to the
spatially distributed pattern associated with a diagno-
sis of BD. This is in contrast to the more stringent
inferential methods used for controlling type I error
to ﬁnd highly localized, spatially segregated focal
group differences. Fourth, regression analyses, thre-
sholded at p<0.001 uncorrected, were implemented
in SPM5 using cumulative exposure to lithium or anti-
psychotics (based on doses transformed to chlorpro-
mazine equivalents) to identify potential effects of
medication on the GM and WM volumes of patients.
GPC discrimination maps
The discrimination map (Rasmussen & Williams, 2006)
is a spatial representation of the vector of GPC predic-
tive weights and describes the relative contribution of
each brain voxel to the classiﬁer decision. Technical
details of GPC discrimination mapping have been
Table 2. Cohort 1: gray matter (GM) regions discriminating between individuals with bipolar disorder (BD) and controls
Region Laterality BA
Coordinates
Cluster sizea Wi
bx y z
Frontal lobe
Middle frontal gyrus R 10 33.3 49.9 11.7 466 −16.7
L 10 −31.6 55.3 7.7 397 −16.6
9 −39 23.9 27.7 93 −21.8
Inferior frontal gyrus L 11 −30.6 35.8 −16.9 71 −14.0
Parietal lobe
Inferior parietal lobule R 40 39.6 −54 41 221 −22.4
L 40 −43.1 −35.8 44.5 569 −16.8
Temporal lobe
Superior temporal gyrus R 41 48.1 −32.1 15.2 76 −14.5
L 39 −52.8 −55.4 23.5 832 −18.4
Fusiform gyrus L 37 −45.7 −59.7 −14.7 210 −16.1
Middle temporal gyrus R 21 57.3 −37.8 −2.4 155 −13.6
L 37 −56.6 −54.1 −8.9 204 −16.3
Occipital lobe
Lingual gyrus R 19 33.3 −63.1 2.7 1759 −18.2
17 7.2 −94.1 2.9 111 −18.0
Cuneus L 18 −4.3 −76.4 6.3 109 −10.0
Superior occipital gyrus L 19 −31.6 −72.9 26.4 84 −15.6
Middle occipital gyrus R 19 29 −76.3 24.2 53 −18.0
Limbic lobe
Parahippocampal gyrus R 28 20.8 −14.6 −19.6 55 −12.8
Anterior cingulate gyrus L 32 −0.4 48.8 5.55 179 −11.7
Posterior cingulate gyrus R 31 0.4 −37.9 40.4 759 −12.2
30 −9.5 −60.4 12.2 71 −9.2
Insula R 13 34.7 9.6 2.2 707 −14.1
L 13 −38.7 16.2 −1.4 747 −15.5
Thalamus L – 0 −18.1 6 184 −14.6
Striatum
Caudate R – 11 15.7 5.7 50 −12.2
L – 7 16.9 6.7 77 –16.1
Cerebellum L – 20.8 −61.4 −53.4 582 −16.2
R – −28.9 −66.3 −52.6 257 −12.5
BA, Brodmann area; R, right; L, left.
Coordinates are shown in Montreal Neurological Institute (MNI) standard space; x=sagittal, y=coronal, z=axial.
a Number of voxels.
b Highest weights within individual clusters.
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published elsewhere (Bishop, 2006; Marquand et al.
2010) and are described in the online Supplementary
Material. The process is illustrated in Fig. 1 based on a
simpliﬁed hypothetical example of a two-voxel image.
Results
Prediction accuracy
Classiﬁcation accuracy reﬂects the predictive power of
the algorithm and is therefore of direct diagnostic rel-
evance. For cohort 1, classiﬁcation accuracy using
GPC analysis of GM images was 73% with a sensitivity
and speciﬁcity of 77% and 69% respectively. In other
words, based on a GM anatomical scan, if a participant
had a clinical diagnosis of BD, the probability of correct
classiﬁcation was 0.77. Conversely, if a participant
did not have BD, the probability of being correctly
classiﬁed as a control was 0.69. The GPC analysis
using WM images for cohort 1 yielded an accuracy of
69% with a sensitivity of 69% and speciﬁcity of 69%.
For cohort 2, the sensitivity and speciﬁcity of the GM
classiﬁcation were 64% and 99% respectively and the
overall accuracy was 72%. In the same cohort, GPC
analysis using WM images yielded an accuracy of
78% with a sensitivity of 71% and speciﬁcity of 86%.
For both cohorts, the models were signiﬁcant at
p<0.001.
Discrimination maps
Discrimination maps showing the global spatial pat-
tern by which the groups differ are illustrated
in Fig. 2 and detailed in Tables 2 (GM) and 3 (WM)
for cohort 1 and in Fig. 3 and Tables 4 (GM) and 5
(WM) for cohort 2. For both cohorts, the maps high-
light those regions that, according to our GPC-RFE
classiﬁcation approach, contain the most discriminat-
ing voxels between BD patients and controls. This opti-
mal discriminative pattern was obtained following
removal of ∼98% of all voxels. Because of the multi-
variate character of the GPC, the discrimination maps
should not be interpreted as describing focal effects
within individual brain regions. Instead they represent
a spatially distributed pattern of coefﬁcients that quan-
tify the contribution of each voxel to the GPC decision
function (i.e. the value of a voxel in the discrimination
map reﬂects its contribution or predictive value
towards one class or the other). We used the following
convention: class 1 was the BD group, with labels +1,
and class 2 was the control group, with labels −1. In
the discrimination map, positive coefﬁcients indicate
Table 3. Cohort 1: white matter (WM) regions discriminating between individuals with bipolar disorder (BD) and controls
Region Laterality
Coordinates
Cluster sizea Wi
bx y z
Frontal lobe
Inferior frontal gyrus L −46 25 17 110 −55.8
Parietal lobe
Inferior parietal lobule L −46 −27 51 363 −44.2
−34 −41 39 186 −30.1
Precuneus R 28 −47 51 156 −44.4
Postcentral gyrus L −26 −23 41 133 28.1
Supramarginal gyrus L −26 −29 29 231 21.1
Occipital lobe
Middle occipital gyrus L −50 −55 7 66 −43.2
R 36 −67 13 1156 −48.9
Cuneus L −12 −79 13 87 −25.8
Precuneus L 20 −49 25 441 23.3
Limbic lobe
Cingulate gyrus L −2 −35 23 832 −35.2
Corpus callosum
Genu R 16 25 9 83 −19.9
L, Left; R, right.
Coordinates are shown in Montreal Neurological Institute (MNI) standard space; x=sagittal, y=coronal, z=axial.
a Number of voxels.
b Highest weights within individual clusters.
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voxels with a predictive value for BD (class 1; visual-
ized in red color scale) and negative coefﬁcients indi-
cate voxels with a predictive value for controls (class
2; visualized in blue color scale); by deﬁnition, a
voxel with negative predictive weight for patients has
the same positive predictive weight for controls.
There is signiﬁcant overlap between the cohorts. In
terms of GM, regions within the frontopolar and ven-
tral prefrontal cortex, the parietal lobules, the middle/
superior temporal gyri, the lingual gyrus and cuneus
and within the thalamus and cerebellum emerge as
being implicated most consistently in the diagnosis of
BD. A similar conclusion can be drawn for WM tracts
traversing ventral prefrontal regions, parietal and post-
central regions, the middle occipital gyrus and the
cuneus, the cingulum and genu of the corpus callosum.
Discriminative regions were more extensive in cohort
2, which consisted of younger and less medicated
patients than cohort 1, suggesting that the results of
the GPCs are not driven by medication or age.
VBM
At the threshold of p<0.0001 uncorrected, GM and
WM volumetric differences between patients and
controls were noted in multiple brain regions in both
cohorts. Details of the regional maxima are provided
in Supplementary Tables S1–S4. As discussed, the out-
put of the GPC and VBM analyses are not directly
comparable as the former reﬂects the predictive value
of voxels in discriminating between patients and con-
trols whereas the latter represents the mean differences
between patients and controls. Nevertheless, there is
signiﬁcant overlap between the two outputs and
between cohorts. An effect of medication was ident-
iﬁed only in cohort 1, with cumulative lithium
exposure being positively associated with the right
anterior cingulate GM volume (x=5.2, y=41.1, z=4,
cluster size=85). No correlations with medication dose
were noted in cohort 2.
Discussion
To our knowledge, this is the ﬁrst study to evaluate the
feasibility of using pattern recognition algorithms for
the automatic classiﬁcation of sMRI data of patients
with BD and healthy controls. We found that GPCs
applied to GM reliably achieved above chance discri-
minative power solely on the basis of anatomical
Table 4. Cohort 2: gray matter (GM) regions discriminating between individuals with bipolar disorder (BD) and controls
Region Laterality BA
Coordinates
Cluster sizea Wi
bx y z
Frontal lobe
Middle frontal gyrus R 10 28.0 41.0 17.0 650 14.369
Parietal lobe
Inferior parietal lobe L 7 −42.0 −69.0 47.0 49 −11.18
Temporal lobe
Middle temporal gyrus L 39 −44.0 −65.0 17.0 29 −73.482
Occipital lobe
Middle occipital gyrus L 18 −30.0 −83.0 −7.0 245 64.639
19 −30.0 −91.0 7.0 32 −92.226
R 18 24.0 −89.0 11.0 17 −10.218
Inferior occipital gyrus R 18 26.0 −91.0 −7.0 184 34.588
Lingual gyrus L 17 −14.0 −97.0 −17.0 193 −11.478
R 17 10.0 −95.0 −17.0 25 −19.075
Cuneus R 23 12.0 −71.0 9.0 90 −21.117
Limbic lobe
Anterior cingulate gyrus L 32 −3.0 42.0 7.0 650 12.45
R 32 5.0 40.0 6.0 650 12.19
Thalamus L – −6.0 −11.0 5.0 69 21.513
Cerebellum R – 28.0 −87.0 −39.0 9 −0.753
BA, Brodmann area; R, right; L, left.
Coordinates are shown in Montreal Neurological Institute (MNI) standard space; x=sagittal, y=coronal, z=axial.
a Number of voxels.
b Highest weights within individual clusters.
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data, with classiﬁcation accuracy ranging between 69%
and 78%.
Prediction accuracy of GPCs applied to sMRI in BD
Neuroanatomical studies using conventional analyses
have established the presence of morphological
changes in BD (Kempton et al. 2008; Arnone et al.
2009; Vita et al. 2009; Bora et al. 2010; Ellison-Wright
& Bullmore, 2010; Kempton et al. 2011; Selvaraj et al.
2012). However, these ﬁndings have had limited trans-
lational application primarily for three reasons: (a)
there is considerable between-group overlap in brain
morphological variables derived from group-level
neuroimaging analyses (Kempton et al. 2008, 2009,
2011), (b) voxel-based analysis methods are signiﬁ-
cantly biased toward detecting group differences that
are highly localized in space but are limited in detect-
ing group differences that are spatially distributed and
subtle (Davatzikos, 2004), and (c) voxel-based analyses
do not lend themselves to making predictions at the
level of individual subjects.
The data presented here demonstrate that these
limitations may be surmounted with the aid of multi-
variate pattern recognition techniques. The application
of GPC analysis to anatomical scans in BD provided
diagnostic accuracy in the range 69–78%. As with
any new test, the accuracy of the GPC classiﬁcation
for BD was determined against ‘gold standard’ diag-
nostic assessments. In this study ‘true positive cases’
(i.e. patients with BD) were identiﬁed using the
SCID-I, conducted by clinicians with expertise in
mood disorders. The SCID-I is designed to elicit the
presence or absence of the operational criteria that
deﬁne the syndrome of BD itself and is therefore expec-
ted to have the highest diagnostic accuracy (Williams
et al. 1992; Fennig et al. 1994; Segal et al. 1994). A
more appropriate comparison would be with behavior-
based case-ﬁnding instruments, whose sensitivity
and speciﬁcity are about 70%, such as the Mood Dis-
order Questionnaire (MDQ; Hirschfeld et al. 2000;
Hirschfeld, 2010; Zimmerman et al. 2011). However,
even more important is the comparison of our results
to ‘real world’ clinical assessments where BD is either
missed or misdiagnosed resulting in nearly a third of
patients having to wait for approximately 10 years
before they receive an accurate diagnosis (Lish et al.
1994; Hirschfeld et al. 2003; Berk et al. 2007). This is
because of the substantial overlap between clinical
symptoms of BD and those of other disorders, par-
ticularly major depressive disorder (MDD) because
depressive symptoms are commonly present at onset
(Perugi et al. 2000) and often dominate the clinical
picture thereafter (Judd et al. 2002). Additionally, the
presence of psychosis during manic or depressive
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episodes often leads to difﬁculties in distinguishing
BD from schizophrenia and schizo-affective disorder
(Schimmelmann et al. 2005). Further diagnostic chal-
lenges arise from the high level of co-morbidity of
BD with other disorders, particularly substance
abuse and anxiety disorders (McElroy et al. 2001; Mer-
ikangas et al. 2011). In this context, a classiﬁer that is
trained to identify true positives BD cases might have
an important role in assisting clinicians when used in
combination with other clinical measures.
The results presented here for the predictive value
of sMRI data in BD compare favorably with classiﬁ-
cation accuracies of approximately 80% reported for
Alzheimer’s disease and schizophrenia, even though
the magnitude of neuroanatomical deviance is
greater for these disorders (reviewed by Klöppel et al.
2012).
Brain regions discriminating patients with BD
from controls
The GM and WM discriminative maps generated
by the GPCs show that clusters contributing to the dis-
tinction between BD patients and healthy controls are
spatially distributed within cortical and subcortical
regions (Tables 2–5). GM discriminative clusters con-
sistently associated with BD in both cohorts were
localized primarily within the frontopolar and ventral
prefrontal cortex, the inferior parietal lobule, the
medial and lateral temporal cortex, the cingulate cor-
tex, occipital regions in the lingual gyrus and cuneus,
the thalamus and cerebellum. This is in keeping with
previous morphometric studies that have repeatedly
shown an association between volumetric changes
in these regions and disease expression for BD
Table 5. Cohort 2: white matter (WM) regions discriminating between individuals with bipolar disorder (BD) and controls
Region Laterality
Coordinates
Cluster sizea Wi
bx y z
Frontal lobe
Medial frontal gyrus R 2 −19 66 415 −89.186
21 39 25 154 −64.624
L −34 34 26 366 −86.983
Inferior frontal gyrus R 40 37 −0 124 −75.911
L −50 8 14 97 −77.191
Middle frontal gyrus R 31 39 17 147 −97.775
28 20 40 126 −92.977
L −18 17 40 171 −65.687
Parietal lobe
Postcentral gyrus L −54 −19 19 413 −74.915
Precuneus R 20 −59 49 313 −10.468
Superior parietal lobule R 22 −43 56 311 −42.827
Temporal lobe
Middle temporal gyrus R 42 −0 −31 160 −89.324
Fusiform gyrus L −50 −24 −26 120 −69.773
Inferior temporal gyrus R 54 −46 −12 119 −38.803
Occipital lobe
Middle occipital gyrus L −27 −71 14 574 −13.083
Inferior occipital gyrus R 27 −93 −8 285 −93.779
Cuneus R 28 −65 12 338 −11.814
Limbic lobe
Cingulate gyrus L −2 −36 27 966 −10.604
Corpus callosum
Genu L −9 29 14 26 −44.234
Cerebellum R 10 −60 −31 121 −52.074
R, Right; L, left.
Coordinates are shown in Montreal Neurological Institute (MNI) standard space; x=sagittal, y=coronal, z=axial.
a Number of voxels.
b Highest weights within individual clusters.
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(Kempton et al. 2008, 2009, 2011; Scherk et al. 2008;
Arnone et al. 2009; Yu et al. 2010; Hallahan et al.
2011). Previous research on global (Scherk et al. 2008;
Vita et al. 2009) and regional (McIntosh et al. 2005;
Stanﬁeld et al. 2009) WM volume changes in BD
yielded variable results. However, there is increasing
consensus for an association between disease
expression for BD and WM pathology within the cin-
gulum (Vederine et al. 2011) and the genu of the corpus
callosum (Bellani et al. 2009; Walterfang et al. 2009a,b;
Bearden et al. 2011). Our ﬁndings in both cohorts
suggest that WM regions of predictive value for BD
patients are widespread but consistently include
the cingulum and genu. Although the results of the
VBM and GPC analyses cannot be compared directly,
they showed signiﬁcant overlap in terms of the spatial
distribution of regions inﬂuenced by the diagnosis
of BD.
Methodological considerations and future directions
In cohort 1, the majority of BD patients were medicated
with antipsychotic or mood-stabilizing medication or
both. Treatment with lithium has been associated
with volumetric changes in BD, and speciﬁcally in-
creases in global and regional volumes (Bearden et al.
2007; Kempton et al. 2008, 2009; Phillips et al. 2008;
Germana et al. 2010; van Erp et al. 2012). In line with
this, we observed a positive association between
lithium dose and GM volume in the anterior cingulate
in cohort 1. However, medication effects related to
lithium or antipsychotics cannot fully explain the
results because patients in cohort 2 were not on these
medications.
The GPCs were trained to segregate healthy controls
from patients with BD. This represents the necessary
ﬁrst step in developing pattern recognition approaches
for use as neurodiagnostic tools. Future studies are
required to replicate these ﬁndings in larger samples
and across different sites. Another important task is
to evaluate the performance of pattern recognition
classiﬁers for the identiﬁcation of biologically mean-
ingful subtypes of BD and for the differential diagnosis
of BD from disorders with overlapping clinical
phenotypes.
In summary, our results demonstrate that GPC-
based neuroanatomical pattern recognition techniques
may prove clinically useful in improving the timely
diagnosis of BD, which currently relies entirely on
clinical symptoms.
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